Malnutrition and Neurodegenerative Diseases

被引:1
作者
Sheard J.M. [1 ]
机构
[1] Chattanooga, TN, 37415
关键词
Alzheimer's disease; Depression; Disease severity; Malnutrition; Malnutrition Screening Tool; Mini-Nutritional Assessment; Nutrition assessment; Nutrition screening; Nutritional status; Parkinson disease; Subjective Global Assessment; Weight loss;
D O I
10.1007/s13668-014-0078-2
中图分类号
学科分类号
摘要
With the aging population, the prevalence of the two most common neurodegenerative disorders, namely Parkinson's disease and Alzheimer's disease, is likely to increase. Given the presence of disease symptoms that are also risk factors for poor nutritional status, weight loss and malnutrition are commonly reported as issues. However, a consensus has not been reached regarding the prevalence and significance of poor nutritional status. Using validated nutrition screening and assessment tools, 14.1-55.9% and 0-12.6% of people with mild Alzheimer's disease are at risk of malnutrition and malnourishment, respectively, while 17.2-23.5% and 0-40% of people with mild to severe Parkinson's disease are at risk of malnutrition and malnourishment, respectively. Disease-specific factors are predictive of nutritional status, and greater disease severity is particularly important. Nutrition intervention data are lacking, but needed, for both diseases. Nutrition screening should occur early in the disease by health professionals with regular patient contact. © 2014 Springer Science+Business Media New York.
引用
收藏
页码:102 / 109
页数:7
相关论文
共 50 条
  • [31] Microbiota and neurodegenerative diseases
    Marizzoni, Moira
    Provasi, Stefania
    Cattaneo, Annamaria
    Frisoni, Giovanni B.
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (06) : 630 - 638
  • [32] Glycosaminoglycans in Neurodegenerative Diseases
    Jin, Weihua
    Zhang, Fuming
    Linhardt, Robert J.
    ROLE OF GLYCOSYLATION IN HEALTH AND DISEASE, 2021, 1325 : 189 - 204
  • [33] Cannabinoids and Neurodegenerative Diseases
    Romero, Julian
    Martinez-Orgado, Jose
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 440 - 450
  • [34] Proteotoxicity and Neurodegenerative Diseases
    Ruz, Clara
    Luis Alcantud, Jose
    Vives Montero, Francisco
    Duran, Raquel
    Bandres-Ciga, Sara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 25
  • [35] Peroxiredoxins in Neurodegenerative Diseases
    Szeliga, Monika
    ANTIOXIDANTS, 2020, 9 (12) : 1 - 19
  • [36] Metallothioneins and neurodegenerative diseases
    Hozumi, I
    Asanuma, M
    Yamada, M
    Uchida, Y
    JOURNAL OF HEALTH SCIENCE, 2004, 50 (04) : 323 - 331
  • [37] Sleep in Neurodegenerative Diseases
    Iranzo, Alex
    SLEEP MEDICINE CLINICS, 2016, 11 (01) : 1 - +
  • [38] Mitoepigenetics and Neurodegenerative Diseases
    Coppede, Fabio
    Stoccoro, Andrea
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [39] Endocannabinoids and neurodegenerative diseases
    Micale, Vincenzo
    Mazzola, Carmen
    Drago, Filippo
    PHARMACOLOGICAL RESEARCH, 2007, 56 (05) : 382 - 392
  • [40] Hallucinations in Neurodegenerative Diseases
    Burghaus, Lothar
    Eggers, Carsten
    Timmermann, Lars
    Fink, Gereon R.
    Diederich, Nico J.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (02) : 149 - 159